Position in PCRX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,928,120
-$476,900 QoQ
Shares Held
76,000
-40.5% QoQ
Ownership
0.191%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 254 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NORGES BANK holds $2,351,821,288 across 19 Drug Manufacturers - Specialty & Generic names. PCRX ranks #17 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
32,299,753 | $1,094,315,631 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
694,753 | $376,438,017 | |
| 3 | ZTS |
Zoetis Inc.
|
4,689,847 | $337,012,405 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
973,880 | $164,137,735 | |
| 5 | ALKS |
Alkermes plc.
|
2,156,814 | $113,017,053 | |
| 6 | HLN |
Haleon plc
|
7,175,000 | $66,942,750 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
586,845 | $65,104,584 | |
| 8 | VTRS |
Viatris Inc
|
3,822,744 | $60,705,174 |
All Filings in PCRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,928,120 | 76,000 | Shares | Sole | 2026-08-12 | |
| 2024-12-31 | $2,405,020 | 127,655 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $4,053,025 | 269,304 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $6,009,730 | 210,057 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,246,706 | 248,005 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $9,541,773 | 282,803 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $9,190,132 | 299,548 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $12,566,232 | 313,607 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $16,465,365 | 403,464 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $15,553,382 | 402,833 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $21,426,687 | 402,833 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $23,500,846 | 403,102 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $31,776,671 | 416,361 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $23,557,036 | 391,508 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $14,533,456 | 259,526 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $18,240,650 | 300,604 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $26,206,651 | 373,900 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $28,203,310 | 471,312 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $28,335,277 | 471,312 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $28,473,737 | 542,667 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $18,146,871 | 541,213 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||